The current STTPF market cap is 0. The company's latest EPS is EUR 1.0081 and P/E is 29.01.
Year End September 29 2023 | 2023 |
---|---|
EUR (€) | |
Total Revenue | 898.6M |
Operating Income | 189.28M |
Net Income | 151.84M |
Year End September 29 2023 | 2023 |
---|---|
EUR (€) | |
Total Assets | 1.23B |
Total Liabilities | 539.65M |
Total Equity | 692.18M |
Year End September 29 2023 | 2023 |
---|---|
EUR (€) | |
Operating | 181.65M |
Investing | -171.41M |
Financing | -11.4M |
Market Cap | 0 |
Price to Earnings Ratio | 29.01 |
Price to Sales Ratio | 4.9 |
Price to Cash Ratio | 180.83 |
Price to Book Ratio | 6.36 |
Dividend Yield | - |
Shares Outstanding | 150.62M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0 (0%) |
Company Name | Schott Pharma AG and Company (PK) |
Address |
hattenbergstrasse 10 mainz 55122 |
Website | https://www.schott-pharma.com |
Industry | drugs and proprietary-whsl (5122) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.